Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Natalie Bartosch
Differential Sensitivity of ERBB2 Kinase Domain Mutations Towards Lapatinib
PLoS ONE
Multidisciplinary
Related publications
Combining Lapatinib (GW572016), a Small Molecule Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, With Therapeutic Anti-ErbB2 Antibodies Enhances Apoptosis of ErbB2-overexpressing Breast Cancer Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
ErbB2 Inhibition by Lapatinib Promotes Degradation of Mutant P53 Protein in Cancer Cells
Oncotarget
Oncology
P2.13-46 Comprehensive Investigation of ERBB2 Transmembrane Domain Mutations (V659/G660) in 12,833 Chinese Lung Cancer Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Disease-Associated Mutations in Conserved Residues of ALK-1 Kinase Domain
European Journal of Human Genetics
Genetics
EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated With Lapatinib Resistance and Neoplastic Transformation
Clinical Cancer Research
Cancer Research
Oncology
Figure 1: Overview of the Kinase Domain of Mps1 and Point Mutations.
Targeting Oncoprotein Stability Overcomes Drug Resistance Caused by FLT3 Kinase Domain Mutations
PLoS ONE
Multidisciplinary
EGFR Kinase Domain Mutations – Functional Impact and Relevance for Lung Cancer Therapy
Oncogene
Cancer Research
Genetics
Molecular Biology
Outcome of Patients With Chronic Myeloid Leukemia With Multiple ABL1 Kinase Domain Mutations Receiving Tyrosine Kinase Inhibitor Therapy
Haematologica
Hematology
